Navigation Links
CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies
Date:4/3/2008

preparations is that it is stabilized with the amino acid proline, giving it excellent stability at room temperature (25 C) for a period of 24 months.

Privigen(R) is indicated for the treatment of primary and secondary immune deficiencies as well as immune thrombocytopenic purpura (ITP), a disorder characterized by low platelet counts due to the presence of auto-antibodies directed against the patient's own platelets.

Privigen(R) is contraindicated in individuals with selective IgA deficiency as well as in patients who have had an anaphylactic or severe systemic reaction to the administration of human immune globulin. The most common adverse events observed with the use of Privigen(R) include: Headache, nausea, fatigue, chills and pain.

Vivaglobin(R) is the first subcutaneously-administered Ig replacement therapy approved in Canada. It has the added benefit of providing stable steady-state serum Ig levels without the peaks and troughs associated with intravenous Ig therapy.

Vivaglobin(R) has been shown in clinical studies to be safe in both adults and children. As with any medication, side effects may accompany treatment. The frequency of side effects was based on a review of more than 3,600 injections given during clinical trials in the United States and Canada. The most frequently reported side effect was injection/infusion site reaction, which generally consisted of a mild or moderate swelling, redness, and itching at the site of injection/infusion. In clinical trials, these reactions tended to decrease substantially after repeated use.

The most frequent adverse events reported by subjects irrespective of causality included headache, gastrointestinal disorder, fever, nausea, sore throat, rash, allergic reaction, pain, diarrhea and increased cough.

Because Privigen(R) and Vivaglobin(R) are made from human plasma, there is a risk, however slight, that they contain pathogens susceptible to cause diseases. This, in theory, al
'/>"/>

SOURCE CSL Behring
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. CSL Behring Expands Into Middle East Market with Haemate(R) P
2. Siemens Completes Acquisition of Dade Behring
3. Siemens Receives EU Antitrust Clearance for Acquisition of Dade Behring
4. AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain Asian Countries
5. Pharsight Signs Two New DMX(R) License Customers
6. Siemens Signs Multi-Year Agreement With Cleveland Clinic to Deploy Enterprise-Wide Cardiology PACS
7. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in Germany
8. Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems
9. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France
10. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
11. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... Ill. , July 18, 2014 /PRNewswire/ ... infographic highlighting AbbVie and Shire,s complementary fit ... A copy of the infographic ... at:  http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-disclaimer-documents In ... Code, a copy of this announcement will ...
(Date:7/18/2014)... The Basel Declaration presented ... third consecutive year. The award winner, Vladimir Sergeevich Popov ... course at Zürich University for research with animals according ... As head of the animal research laboratory at the ... of adapting experimental animal research as well as student ...
(Date:7/17/2014)... 17, 2014  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... development and commercialization of products for the treatment of ... results for the second quarter of 2014 on Thursday, ... The Company will host a conference call at ... which Vanda management will discuss the second quarter 2014 ...
(Date:7/17/2014)... July 17, 2014  Prana Biotechnology (NASDAQ: ... on its clinical development program for Alzheimer,s disease. ... of Neuroscience and Mental Health, The University of Melbourne, ... and EURO trials in his presentation at the Alzheimer,s ... . The presentation is entitled: "How ...
Breaking Biology Technology:NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 2NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 3NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 4NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 5NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 6NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 7Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research" 2Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2Prana Alzheimer's disease Development Program update 2Prana Alzheimer's disease Development Program update 3Prana Alzheimer's disease Development Program update 4Prana Alzheimer's disease Development Program update 5
... Do the principles of quantum mechanics apply to biological ... Institute,s Chemical Physics Department (Faculty of Chemistry), both biologists ... to be like apples and oranges. But research he ... in Science , definitively shows that a biological ...
... China March 31, 2011 /PRNewswire-Asia/ -- Tiens Biotech Group (USA), ... ), a company dedicated to the research, development, ... and dietary supplements, today announced financial results for ... revenue was $41.3 million, compared to $62.0 million for 2009. ...
... March 31, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: ... developer, manufacturer and distributor of probiotics products in China, ... sales order from its newly signed U.S. customer. ... first sales order, and formally entered into its agreement ...
Cached Biology Technology:Biological molecules select their spin 2Tiens Biotech Group (USA) Reports 2010 Results 2Tiens Biotech Group (USA) Reports 2010 Results 3Tiens Biotech Group (USA) Reports 2010 Results 4Tiens Biotech Group (USA) Reports 2010 Results 5Tiens Biotech Group (USA) Reports 2010 Results 6Tiens Biotech Group (USA) Reports 2010 Results 7China-Biotics Receives First U.S. Sales Order 2China-Biotics Receives First U.S. Sales Order 3
(Date:7/21/2014)... many times do we see an innovation and think, ... minds start turning towards thoughts of our own invention, ... is the concept behind the International Space Station Program ... see what their colleagues have going on in orbit, ... "Our goal is to encourage investigators to propose new ...
(Date:7/21/2014)... -- Why does the word "dog" have meaning? If ... friend understand you? , Kansas State University philosopher Elliott ... his latest research, which focuses on long-standing philosophical questions ... two other philosophers and a mathematician are collaborating to ... acquires meaning. , "If I order a cappuccino at ...
(Date:7/21/2014)... disease often results from the strength of immune response, ... response, rather than attacking the virus, might be a ... of the University of Washington, Seattle. She and her ... just that for the H7N9 influenza, and their work ... for this highly virulent strain. The research is published ...
Breaking Biology News(10 mins):International Space Station researcher guides aim to maximize science 2International Space Station researcher guides aim to maximize science 3International Space Station researcher guides aim to maximize science 4Philosopher uses game theory to understand how words, actions acquire meaning 2Potential new flu drugs target immune response, not virus 2
... studies continue to validate the use of probiotics to ... for probiotics indicates that the U.S. healthcare community and ... microorganisms. However, because most probiotics are classified as dietary ... individual needs can be challenging. And, as the ...
... The Seventh Annual Symposium on Predictive Health, to ... on health and the human microbiome. The human microbiome ... and viruses, which reside throughout the body. Study ... attention across the United States, including a major federal ...
... of Atlantic salmon (Salmo salar), which have been ... new challenges in the Gulf of Maine, where ... new predators along altered migration routes are affecting ... in the journal Fisheries Management and Ecology, ...
Cached Biology News:As probiotics use grows for gut health, VSL#3 has designations for specific GI issues 2As probiotics use grows for gut health, VSL#3 has designations for specific GI issues 3Predictive health symposium will focus on human microbiome 2Environmental conditions and predators affect Atlantic salmon survival in the Gulf of Maine 2
...
... catalyzes the formation of phosphodiester bonds in ... with 3' hydroxyl and 5' phosphate termini. ... ligation which can be performed in 5 ... substrates for this enzyme. A T4 ...
Porcine Aortic Endothelial Cells (PAOEC) (>500,000 cells)...
Bovine Endometrium Epithelial Cells (BEnEpC) (>500,000 cells)...
Biology Products: